The online reseller trading as Adamant Research Supply closes after 11 years
A proper account of an operation that existed, and of what closing it cost.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 4 of 49 of this archive, newest first.
A proper account of an operation that existed, and of what closing it cost.
Efficacy was never the question in this appraisal. Duration of treatment was.
A proper account of an operation that existed, and of what closing it cost.
Efficacy was never the question in this appraisal. Duration of treatment was.
The evidence base is thin and the document says so, which is to its credit.
The evidence base is thin and the document says so, which is to its credit.
The observation that closes a facility is rarely the dramatic one.
A proper account of an operation that existed, and of what closing it cost.
The document is four pages. Three of them are about dates.
The evidence base is thin and the document says so, which is to its credit.
The document is four pages. Three of them are about dates.
The evidence base is thin and the document says so, which is to its credit.
A proper account of an operation that existed, and of what closing it cost.
The evidence base is thin and the document says so, which is to its credit.
The evidence base is thin and the document says so, which is to its credit.
The observation that closes a facility is rarely the dramatic one.
Efficacy was never the question in this appraisal. Duration of treatment was.
Efficacy was never the question in this appraisal. Duration of treatment was.
A proper account of an operation that existed, and of what closing it cost.
The evidence base is thin and the document says so, which is to its credit.